ProShare Advisors’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
ProShare Advisors's ASTH Position: Q3 2026 in Review
ProShare Advisors reduced its Astrana Health (ASTH) stake by 4% in Q3 2026, selling an estimated $10.1K and leaving 6,214 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.
ProShare Advisors first reported a position in ASTH in Q2 2021 and has held it in 19 quarters since. The position peaked at $693K in Q4 2021. 96 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.
- ProShare Advisors held 6,214 shares of Astrana Health worth $221K as of Q3 2026.
- ProShare Advisors sold 257 Astrana Health shares in Q3 2026, an estimated $10.1K.
- Astrana Health made up ﹤0.01% of ProShare Advisors's portfolio in Q3 2026, its #1515 holding.
- ProShare Advisors first reported a position in Astrana Health in Q2 2021 and has held it in 19 quarters since.
- ProShare Advisors's Astrana Health position peaked at $693K in Q4 2021.
- 96 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.
Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.